Inhaled mannitol for cystic fibrosis-Reference-Cited by-同舟云学术

Inhaled mannitol for cystic fibrosis

Published:2020-05-01 Issue:5 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Nevitt Sarah J¹,Thornton Judith²,Murray Clare S³,Dwyer Tiffany⁴⁵

Affiliation:

1. Department of Biostatistics; University of Liverpool; Liverpool UK

2. Centre for Clinical Practice; National Institute for Health and Care Excellence; Manchester UK

3. Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair; University of Manchester and University Hospital of South Manchester; Manchester UK

4. Central Clinical School, Sydney Medical School; University of Sydney; Sydney Australia

5. Discipline of Physiotherapy, Faculty of Health Sciences; University of Sydney; Sydney Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference117 articles.

1. Bronchitol (inhaled dry powder mannitol) in adult patients with cystic fibrosis;Aitken;Journal of Cystic Fibrosis,2012

2. Phase III study [CF-302] of inhaled dry powder mannitol (Bronchitol™) in cystic fibrosis - results from the 6 month open label phase;Aitken;Journal of Cystic Fibrosis,2011

3. Efficacy and safety by age group from the phase III studies of bronchitol (inhaled mannitol) in patients with CF;Aitken;Pediatric Pulmonology,2011

4. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study;Aitken;American Journal of Respiratory and Critical Care Medicine,2012

5. Six-month administration of inhaled mannitol in cystic fibrosis - a safety and efficacy study;Aitken;Pediatric Pulmonology,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dry Powder Inhaler Formulation of Lactobacillus rhamnosus GG Targeting Pseudomonas aeruginosa Infection in Bronchiectasis Maintenance Therapy;Pharmaceutics;2024-07-25

2. Tolerability of the first inhaled mannitol dose in children with cystic fibrosis;PULMONOLOGIYA;2024-07-17

3. Expert group recommendation on inhaled mucoactive drugs in pediatric respiratory diseases: an Indian perspective;Frontiers in Pediatrics;2023-12-04

4. The effectiveness of hyaluronic acid in reducing adverse effects associated with inhaled hypertonic saline therapy in patients with cystic fibrosis: A systematic review and meta-analysis;Canadian Journal of Respiratory Therapy;2023-10-31

5. Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis;Drug Discovery Today;2023-10